Prudential Financial
EPZM

Prudential Financial’s Epizyme, Inc EPZM Stock Holding History

Prudential Financial’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-230,790
Closed -$265K – 2792
2022
Q1 		$265K Buy
230,790
+107,750
+88% +$176K ﹤0.01% 2442
2021
Q4 		$308K Buy
123,040
+85,725
+230% +$337K ﹤0.01% 2395
2021
Q3 		$191K Buy
+37,315
New +$227K ﹤0.01% 2485
2020
Q3 		– Sell
-13,063
Closed -$210K – 2502
2020
Q2 		$210K Buy
+13,063
New +$228K ﹤0.01% 2247
2015
Q2 		– Sell
-16,000
Closed -$300K – 2269
2015
Q1 		$300K Buy
+16,000
New +$330K ﹤0.01% 2074

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Prudential Financial's EPZM Position: Q2 2022 in Review

Prudential Financial sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 230,790 shares — an estimated $265K sold.

Prudential Financial first reported a position in EPZM in Q1 2015 and held it in 5 quarters. The position peaked at $308K in Q4 2021. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Prudential Financial reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Prudential Financial sold 230,790 Epizyme, Inc shares in Q2 2022, an estimated $265K.
  • Prudential Financial first reported a position in Epizyme, Inc in Q1 2015 and held it in 5 quarters.
  • Prudential Financial's Epizyme, Inc position peaked at $308K in Q4 2021.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Prudential Financial's 13F filing for Q2 2022, filed 15 Aug 2022.